|
Market Closed -
Oslo Bors
17:45:00 06/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 272.00 NOK | +5.02% |
|
+8.37% | +5.02% |
| 09-21 | Medistim ASA(OB:MEDI) added to S&P Global BMI Index | CI |
| 09-15 | Odin Small Cap rose 4.15% in August, 16 holdings beat expectations | FW |
| Market Cap | 4.98B 521M 463M 433M 393M 735M 50.2B 746M 5.2B 2.02B 25.63B 1.96B 1.91B 82.16B | P/E 2026 * |
27.2x | P/E 2027 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.84B 507M 450M 421M 382M 715M 48.81B 726M 5.06B 1.97B 24.92B 1.9B 1.86B 79.89B | EV / Sales 2026 * |
6.06x | EV / Sales 2027 * | 5.55x |
| Free-Float |
79.47% | Yield 2026 * |
3.17% | Yield 2027 * | 3.29% |
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| MEDI | Real-time | |
CBOE
| MEDIo | Real-time | |
Nasdaq Stockholm
| MEDIO | Delayed | |
Nasdaq Stockholm
| MEDIO | End-of-day quote | |
Börse Stuttgart
| MD1 | Delayed | |
Deutsche Boerse AG
| MD1 | Delayed | |
Boerse Muenchen
| MD1 | Real-time | |
CBOE
| 0OCD | Real-time |
Last Transcript: Medistim ASA
| 1 day | +5.02% | ||
| 1 week | +8.37% | ||
| Current month | +7.51% | ||
| 1 month | +8.80% | ||
| 3 months | +19.30% | ||
| 6 months | +27.10% | ||
| Current year | +5.02% |
| 1 week | 250 | 273 | |
| 1 month | 240 | 273 | |
| Current year | 186.5 | 273 | |
| 1 year | 186.5 | 292 | |
| 3 years | 130 | 292 | |
| 5 years | 130 | 402.5 | |
| 10 years | 60 | 409 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 01/09/2009 | |
| Director of Finance/CFO | - | 01/01/2001 | |
Jonas Tysso
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 01/01/2000 | |
Tove Raanes
BRD | Director/Board Member | 49 | 01/01/2014 |
| Director/Board Member | 56 | 01/04/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/4/25 A | Buy | Chairman | 860,735 | 4.6939% | ||
| 1/27/25 A | Buy | Chairman | 45,000 | 0.2454% | ||
| 1/9/25 A | Buy | Chairman | 30,000 | 0.1636% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.02% | +8.37% | +14.77% | +28.91% | 494M | ||
| -2.98% | -3.24% | +20.85% | +31.84% | 250B | ||
| -2.53% | -5.16% | +0.29% | -0.58% | 156B | ||
| -0.42% | -2.42% | -10.52% | +39.53% | 144B | ||
| -0.50% | -4.35% | -56.65% | -18.36% | 61.45B | ||
| -0.86% | -0.40% | +12.21% | +19.78% | 50.28B | ||
| +1.66% | -1.55% | -20.09% | -20.26% | 46.73B | ||
| -1.00% | -3.36% | +19.55% | +53.45% | 48.29B | ||
| +0.02% | +1.26% | -4.31% | +40.76% | 45.89B | ||
| -0.84% | -1.47% | +32.90% | +64.08% | 43.24B | ||
| Average | +0.39% | -1.77% | +0.90% | +23.91% | 84.57B | |
| Weighted average by Cap. | -0.58% | -2.77% | +2.51% | +23.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 798M 83.6M 74.26M 69.52M 63M 118M 8.06B 120M 834M 324M 4.11B 314M 307M 13.19B | 868M 90.93M 80.77M 75.61M 68.52M 128M 8.76B 130M 908M 353M 4.47B 341M 334M 14.34B |
| Net income | 182M 19.11M 16.97M 15.89M 14.4M 26.96M 1.84B 27.38M 191M 74.15M 940M 71.72M 70.18M 3.01B | 203M 21.25M 18.88M 17.67M 16.02M 29.98M 2.05B 30.45M 212M 82.48M 1.05B 79.77M 78.06M 3.35B |
| Net Debt | -138M -14.4M -12.79M -11.97M -10.85M -20.31M -1.39B -20.63M -144M -55.87M -708M -54.03M -52.87M -2.27B | -158M -16.6M -14.74M -13.8M -12.5M -23.41M -1.6B -23.78M -166M -64.4M -817M -62.29M -60.95M -2.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | NOK 272.00 | +5.02% | 90,428 |
| 05/10/26 | NOK 259.00 | +3.60% | 24,613 |
| 02/10/26 | NOK 250.00 | -1.19% | 11,420 |
| 01/10/26 | NOK 253.00 | 0.00% | 9,980 |
| 30/09/26 | NOK 253.00 | +0.40% | 16,094 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDI Stock
Select your edition
All financial news and data tailored to specific country editions

















